Stefanie Marx
Overview
Explore the profile of Stefanie Marx including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
321
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Urschel R, Bronder S, Klemis V, Marx S, Hielscher F, Abu-Omar A, et al.
Nat Commun
. 2024 Apr;
15(1):3077.
PMID: 38594497
Knowledge is limited as to how prior SARS-CoV-2 infection influences cellular and humoral immunity after booster-vaccination with bivalent BA.4/5-adapted mRNA-vaccines, and whether vaccine-induced immunity may indicate subsequent infection. In this...
2.
Bronder S, Mihm J, Urschel R, Klemis V, Schmidt T, Marx S, et al.
NPJ Vaccines
. 2024 Feb;
9(1):25.
PMID: 38326340
Knowledge on immunogenicity of the bivalent Omicron BA.4/5 vaccine in dialysis patients and the effect of a previous infection is limited. Therefore, vaccine-induced humoral and cellular immunity was analyzed in...
3.
Hielscher F, Schmidt T, Klemis V, Wilhelm A, Marx S, Abu-Omar A, et al.
J Clin Virol
. 2022 Oct;
157:105321.
PMID: 36279695
Background: The NVX-CoV2373-vaccine has recently been licensed, although knowledge on vaccine-induced humoral and cellular immunity towards the parental strain and variants of concern (VOCs) in comparison to mRNA-regimens is limited....
4.
Klemis V, Schmidt T, Schub D, Mihm J, Marx S, Abu-Omar A, et al.
Nat Commun
. 2022 Aug;
13(1):4710.
PMID: 35953492
Comparative analyses of the immunogenicity and reactogenicity of homologous and heterologous SARS-CoV-2 vaccine-regimens will inform optimized vaccine strategies. Here we analyze the humoral and cellular immune response following heterologous and...
5.
Theobald L, Stroeder R, Melchior P, Iordache I, Tanzer T, Port M, et al.
Mol Oncol
. 2021 Sep;
15(12):3559-3577.
PMID: 34469022
Cervical cancer therapy is still a major clinical challenge, as patients substantially differ in their response to standard treatments, including chemoradiotherapy (CRT). During cervical carcinogenesis, T-helper (Th)-17 cells accumulate in...
6.
Schmidt T, Klemis V, Schub D, Mihm J, Hielscher F, Marx S, et al.
Nat Med
. 2021 Jul;
27(9):1530-1535.
PMID: 34312554
Heterologous priming with the ChAdOx1 nCoV-19 vector vaccine followed by boosting with a messenger RNA vaccine (BNT162b2 or mRNA-1273) is currently recommended in Germany, although data on immunogenicity and reactogenicity...
7.
Hauser I, Marx S, Sommerer C, Suwelack B, Dragun D, Witzke O, et al.
Eur J Immunol
. 2020 Dec;
51(4):943-955.
PMID: 33306229
Post-transplant cytomegalovirus (CMV) infections and increased viral replication are associated with CMV-specific T-cell anergy. In the ATHENA-study, de-novo everolimus (EVR) with reduced-exposure tacrolimus (TAC) or cyclosporine (CyA) showed significant benefit...
8.
Marx S, Adam C, Mihm J, Weyrich M, Sester U, Sester M
Front Immunol
. 2020 Jun;
11:916.
PMID: 32499781
Dosage of immunosuppressive drugs after transplantation critically determines rejection and infection episodes. In this study, a global immune function assay was characterized among controls, dialysis-patients, and transplant-recipients to evaluate its...
9.
Weber L, Marx S, Auffarth G, Scheuerle A, Tandogan T, Mayer C, et al.
J Ophthalmic Inflamm Infect
. 2019 Jan;
9(1):3.
PMID: 30694420
Background: A retrospective observational clinical study to evaluate the safety and effectiveness of the injectable 0.19-mg fluocinolone acetonide intravitreal implant (ILUVIEN) in the treatment of non-infectious uveitic macular edema. Results:...
10.
Crossey F, Marx S, Holters S, Schmitt K, Bohle R, Schmidt T, et al.
Urol Oncol
. 2018 Aug;
36(9):402.e1-402.e10.
PMID: 30072305
Background: Tumor-infiltrating lymphocytes (TIL) play an important role in the pathogenesis of renal cell carcinoma. Characterization of TIL requires efficient isolation procedures, especially in early stage disease when the tumor...